Sign In
Buy SGHT
$4.34
+0 (+0%)
At Close: Jun 03, 2026
Mean signs and symptoms for participants in Stage 3 of the SAHARA trial remained statistically significantly better than study baseline at all time points measured up to 24 months Mean signs and sympt
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
04:05pm, Thursday, 24'th Jul 2025
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercia
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th
04:05pm, Wednesday, 14'th May 2025
MENLO PARK, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innova
Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript
01:26am, Sunday, 11'th May 2025
Sight Sciences, Inc. (NASDAQ:SGHT ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Hannah Jefferies - Investor Relations Paul Badawi - Co-Founder & CEO Ali Bauerlein - CF
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:30pm, Thursday, 08'th May 2025
While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics co
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
06:50pm, Thursday, 08'th May 2025
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.33 per share a year ago.
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
04:05pm, Thursday, 08'th May 2025
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologie
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
04:05pm, Thursday, 24'th Apr 2025
MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commerci
Sight Sciences Announces the Release of its Sustainability Report
04:05pm, Wednesday, 23'rd Apr 2025
MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technolog
Sight Sciences Appoints Gary Burbach to its Board of Directors
04:05pm, Tuesday, 22'nd Apr 2025
MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing inn
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
04:05pm, Monday, 21'st Apr 2025
New system features higher viscoelastic capacity and TruSync™ technology, engineered to safely synchronize surgical control and precision in implant-free, comprehensive MIGS New system features high
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
04:05pm, Tuesday, 25'th Mar 2025
MENLO PARK, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commerci
Sight Sciences, Inc. (SGHT) Q4 2024 Earnings Conference Call Transcript
10:06pm, Wednesday, 05'th Mar 2025
Sight Sciences, Inc. (NASDAQ:SGHT ) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ET Company Participants Philip Trip Taylor - IR Paul Badawi - Co-Founder & CEO Alison Bauerlein - CFO Matt Li
Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics
07:00pm, Wednesday, 05'th Mar 2025
While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates
06:20pm, Wednesday, 05'th Mar 2025
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.22 per share a year ago.
